Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer

Fig. 2

Genetic alterations and survival analysis of miR-206 in ovarian cancer. a, b Graphs indicate the frequency of miR-206 somatic mutations in ovarian cancers extracted from cancer studies in TCGA (TCGA, PanCancer Atlas (a) and TCGA, Nature 2011 (b)). c, d Kaplan–Meier diagrams showing the overall survival of patients with ovarian cancer (c) and grade 3 ovarian cancer (d) depending on the expression of miR-206 in kmplot.com

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us